Wealth Awesome
TSX open
Loading markets…
PARTNER SPOTLIGHT
CIBC Investor's Edge

Trade ETFs with $0 commission

Buy and sell over 200 ETFs to build your portfolio, commission-free.¹

  • ✓Over 200 eligible ETFs, commission-free when you trade online
  • ✓Screeners and tools to find ETFs that fit your goals
  • ✓Any account type, backed by the CIBC Digital Banking Guarantee

¹Online trades in ETFs on the Eligible ETF List; hold at least one business day. ETF fund fees still apply. Conditions apply.

Stocks/TSX/BLCO

Bausch + Lomb Corp (BLCO : TSX)

$29.89CAD-0.22 (-0.73%)Close of 2026-11-16

Common Stock

Follow BLCO

BLCO

Bausch + Lomb Corp

Source:WealthAwesomeWealthAwesome
↑ $5.48 (22.45%)
30 day period
$22.51$26.48$30.46Oct 5Oct 27Nov 16

Performance

1 Day

-0.73%

1 Week

+1.49%

1 Month

+29.23%

YTD

+31.15%

The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.

Key Statistics

Market Cap

$10.89B

52W High

$30.46

52W Low

$20.25

P/E Ratio

-

50 Day MA

$25.15

200 Day MA

$23.33

Beta

0.52

Dividend Yield

-

WA Score

How BLCO stacks up against 944 Canadian stocks

out of 99

  • Value45

    Not profitable over the last 12 months.

  • Quality
  • Momentum86

    31.2% this year, above its 200-day average, 94% of the way up its 52-week range.

  • Analysts
  • Insiders

Each factor is a percentile against Canadian common stocks worth $50M or more on the TSX and TSX Venture (90 = better than 90% of them). Built from exchange prices, company financials, analyst targets and SEDI insider filings. A data summary, not advice. How it works · Top-scoring stocks

Performance history

BLCO returns since 2022

Bausch + Lomb Corp has traded since May 2022 in our data, with 2 up years out of 3 full calendar years. Its deepest fall was −50.0% (Dec 2024 to May 2025).

1 year / yr

+41.5%

3 years / yr

+11.3%

5 years / yr

—

10 years / yr

—

Calendar-year returns

  • 2022*−17.5%
  • 2023+7.7%
  • 2024+14.5%
  • 2025−9.7%
  • 2026*+27.5%

* Partial year (first year of data, or year to date).

$10,000 invested in BLCO

  • 1 year ago$14,152
  • 2022 (start of our data)$11,722
Best year
2024: +14.5%
Worst year
2025: −9.7%
All-time high in our data
$30 on Nov 11, 2026 · now −1.9%

Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), May 2022 to Nov 2026. Past returns do not predict future ones.

Earnings

BLCO earnings history

Bausch + Lomb Corp beat the EPS estimate in 2 of its last 4 reported quarters.

Next report

Feb 17, 2027 · before open

EPS estimate $0.37

-0.07000.14500.3600 24-1225-0325-0625-0925-1226-0326-0626-09 Estimate Actual (≥0) Actual (<0) Wealth Awesome
Quarter endingReportedEPSEstimateSurprise
Sep 30, 2026Oct 28, 2026$0.34$0.22+54.5%
Jun 30, 2026Jul 29, 2026$0.16$0.16+0.0%
Mar 31, 2026Apr 29, 2026$0.08$0.05+60.0%
Dec 31, 2025Feb 18, 2026$0.32$0.36−11.1%
Sep 30, 2025Oct 29, 2025$0.18$0.16+12.5%
Jun 30, 2025Jul 30, 2025$0.07$0.09−22.2%
Mar 31, 2025Apr 30, 2025−$0.07$0.02−450.0%
Dec 31, 2024Feb 19, 2025$0.25$0.23+6.8%

EPS as reported vs consensus estimate. TSX earnings calendar →

Awesome Portfolio™

Looking past BLCO? Our 10 best Canadian stocks, in one list.

14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.

See the portfolio →

Bausch + Lomb Corp insider transactions

Open-market and private equity trades (last 12 months volume). Derivatives and opening balances excluded.

Shares soldShares bought0–3 monthsSold by individuals: 5.7M5.7M3–6 monthsSold by individuals: 53k53k6–9 monthsSold by individuals: 20kBought by individuals: 38k38k20k9–12 monthsSold by individuals: 244kBought by individuals: 9k9k244k
Sold · individuals Sold · companies Bought · individuals Bought · companies

Recent transactions

DateSideNameSharesPrice
Oct 29, 26Sell
Munsch, Frederick John
Individual · CA$2.3m
112,015CA$20.48
Oct 11, 26Sell
Saunders, Brenton Lawrence
Individual
2,488,644—
Oct 11, 26Sell
Saunders, Brenton Lawrence
Individual
541,971—
Oct 11, 26Sell
Saunders, Brenton Lawrence
Individual
2,559,586—
Aug 10, 26Sell
Munsch, Frederick John
Individual · CA$8,365
500CA$16.73
Aug 10, 26Sell
Munsch, Frederick John
Individual · CA$2,037
121CA$16.84
Aug 10, 26Sell
Munsch, Frederick John
Individual · CA$39,332
2,344CA$16.78
Aug 10, 26Sell
Munsch, Frederick John
Individual · CA$25,148
1,500CA$16.77
Aug 10, 26Sell
Munsch, Frederick John
Individual · CA$3,354
200CA$16.77
Aug 10, 26Sell
Munsch, Frederick John
Individual · CA$22,603
1,343CA$16.83

Full BLCO insider trading page →

Technical Indicators

Price vs 50-Day SMA

↑Above 50 SMA

Price vs 200-Day SMA

↑Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
11/16/2026$30.64$30.64$29.88$29.89$29.8915,700
11/13/2026$30.17$30.32$29.98$30.11$30.111,207
11/12/2026$30.20$30.26$29.88$30.09$30.091,914
11/11/2026$30.32$30.46$30.21$30.46$30.461,162
11/10/2026$29.35$30.36$29.34$30.34$30.343,296
11/9/2026$28.36$29.45$28.24$29.45$29.453,724
11/6/2026$27.73$28.30$27.73$28.19$28.191,015
11/5/2026$28.61$28.79$27.91$27.96$27.962,401
11/4/2026$28.61$28.80$28.49$28.77$28.77701
11/3/2026$27.86$27.98$27.86$27.98$27.98600

Analyst Price Targets

Based on analyst covering BLCO · as of Nov 13, 2026

📉

Wall Street analysts forecast BLCO stock price to fall 10.0% over the next 12 months.

Consensus

Moderately Bearish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$26.90

-10.0% Upside

Previously C$26.68 on Nov 11, 2026

Current Price

C$29.89

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on BLCO's historical volatility

HistoricalForecast68%95%
C$17.62C$28.58C$39.54C$50.50C$61.46C$72.42TodayJul 9Sep 14Nov 16Dec 29Feb 11Mar 26

30-Day Vol

56.6%

Annualized

90-Day Vol

38.7%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$35.73

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$31.72C$26.09 – C$38.57
60 trading daysC$33.67C$25.54 – C$44.39
90 trading daysC$35.73C$25.47 – C$50.13

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Bausch + Lomb Corp

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

Financials

Revenue (TTM)
$5.42B
EBITDA
$914.00M
Profit Margin
-2.05%
ROE (TTM)
-1.58%
EPS (Diluted)
-0.44
Book Value
25.30

Classification

Sector
Health Care
Industry
Health Care Equipment & Supplies
Group
Health Care Equipment & Services

Free newsletter

The Tuesday Stock Pick

Tuesday morning

One Canadian stock and the case for it

  • The name with the biggest gap to analyst targets
  • The chart, insider buying and what is driving it
  • A plain-English bottom line, no hype

Free. One email a week. Unsubscribe any time.

Common Questions About BLCO

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
HWOHigh Arctic Energy Services Inc.$1.74+29.85%
AAVAdvantage Oil & Gas Ltd.$13.45+23.74%
LUCLucara Diamond Corp$0.13+13.64%
TTelus Corp$13.70+12.85%
FRXFennec Pharmaceuticals Inc$18.35+10.81%
KELKelt Exploration Ltd.$12.72+10.70%
NVONovo Resources Corp$0.07+8.33%
ELOEloro Resources Ltd.$1.23+7.89%

Latest BLCO news

Wire stories from the last 10 days. Tap a headline for a preview.

  • Yahoo Finance · 3d ago

Free with a Wealth Awesome account

Keep analysing BLCO, free

  • Every WA Score, ranking and table
  • Insider track records and SEDI filings
  • Earnings history and analyst targets for every stock

Email only, no password, no card. Already a member? Use the same button to sign in.